Aurinia Pharmaceuticals Inc
11.34 - 11.965
8.86 - 33.97
Join Discuss about AUPH with like-minded investors
institutions loading up on bios during this sell off. Big pharma facing a patent cliff. $MYOV black rock tripled holding size, Bellevue doubled to close to 12%. Biotech 2nd half is going to be buyout land, MYOV, BCRX, AUPH, CLVS anything with a drug that produce revenues
60 Replies 15 👍 13 🔥
nice recovery with that BCRX i bought today ... AUPH not so much
142 Replies 13 👍 14 🔥
ATVI - position sizing should probably reflect risk not confidence (lol) ENPH - "BT69 PLAYED HIMSELF .. got em" rebounded significantly ($120 -> $237) AUPH - "BT69 PLAYED HIMSELF .. got em". got some nice biglyness ($10 -> $30) most of the losers are short term risk (options), oversized positions gone wrong, or both!
89 Replies 6 👍 10 🔥
for the very first time in a long time my entire portfolio is on fire except CLOV NVDA Apple TSLA AQST AUPH LCID SAVA
58 Replies 13 👍 13 🔥
@marketjay hope you having a relaxing weekend. Last week overall very green couple of my key holdings LCID and AUPH went ballistic alongside NVDA. Disappointed with Apple but glad Apple did hold strong steady support around 147.00. Question I have is on $ATER earnings November 8th Short Interest increased and as of last update at 43.00% 99% utilization. Whats your read on $ATER ?
62 Replies 10 👍 11 🔥
What do you all think is big mover tomorrow? DWAC, PHUN, MARK, AUPH, BENE?
40 Replies 10 👍 13 🔥
not familiar with AUPH
91 Replies 10 👍 8 🔥
Agree I guess I will just hold. It's really looking like it will be one of the fastest retrace back to pre split levels. Super Green Day for my core holdings of NVDA NARA AUPH but Apple is lagging.
53 Replies 6 👍 13 🔥
Today I bought: CBAY, BFLY, AUPH, CRON, NNDM
147 Replies 13 👍 13 🔥
Next Dividend Date
Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company’s head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.
CEO: Peter Greenleaf
HQ: 1203-4464 Markham St Victoria, V8Z 7X8 British Columbia